Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
94,938,677
-
Share change
-
-12,736,758
-
Total reported value
-
$1,598,252,322
-
Put/Call ratio
-
53%
-
Price per share
-
$16.83
-
Number of holders
-
287
-
Value change
-
-$223,745,245
-
Number of buys
-
117
-
Number of sells
-
137
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2021
As of 30 Jun 2021 TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) had 287 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 94,938,677 shares of stock of the company.
Largest 10 holders included ARK Investment Management LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, MACQUARIE GROUP LTD, NORTHERN TRUST CORP, Parametric Portfolio Associates LLC, Mondrian Investment Partners LTD, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, and WELLS FARGO & COMPANY/MN.
This table shows 287 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.